IMCB PJSC Logo

IMCB PJSC

Personal biobank preserving umbilical cord stem cells for families' future therapeutic use.

GEMA | MOEX

Overview

Corporate Details

ISIN(s):
RU000A100GC7
LEI:
Country:
Russian Federation
Address:
Gubkina St. House 3, 11933 Moscow
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

IMCB PJSC is a biotechnology company and a leading personal stem cell biobank, operating under the Gemabank brand. The company specializes in the processing and long-term cryopreservation of hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from umbilical cord tissue. These services provide families with a personalized biological resource for potential use in cell therapy to treat a wide range of hematological, immune, and genetic disorders. Established in 2003, the company manages tens of thousands of client biomaterial samples and has a documented history of successfully providing them for clinical applications. IMCB is also engaged in research and development of innovative gene therapy and biopharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all IMCB PJSC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IMCB PJSC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IMCB PJSC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

genOway Logo
Develops custom genetically modified preclinical models for biopharma and academic research.
France
ALGEN
Genprex, Inc. Logo
A clinical-stage firm developing non-viral gene therapies for cancer and diabetes.
United States of America
GNPX
Genxone Spolka Akcyjna Logo
A biotech firm offering nanopore DNA/RNA sequencing services and medical diagnostics.
Poland
GX1
GeoVax Labs, Inc. Logo
Developing vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.
United States of America
GOVX
GH Research PLC Logo
Clinical-stage biopharma developing mebufotenin therapies for psychiatric disorders.
United States of America
GHRS
GI Innovation Inc. Logo
Develops fusion protein biologics for oncology, allergic, and metabolic diseases.
South Korea
358570
Ginkgo Bioworks Holdings, Inc. Logo
A cell programming platform offering R&D services for pharma, agriculture, food, and chemicals.
United States of America
DNA
GRAIL, Inc. Logo
A biotech company that detects multiple cancers early with a single blood test.
United States of America
GRAL
GT Biopharma, Inc. Logo
Develops TriKE® immunotherapies engaging NK cells to treat hematologic and solid tumor cancers.
United States of America
GTBP
Guard Therapeutics International AB Logo
Clinical-stage biotech developing drugs to prevent acute kidney injury during open-heart surgery.
Sweden
GUARD

Talk to a Data Expert

Have a question? We'll get back to you promptly.